Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 18;19(1):113.
doi: 10.1186/s12911-019-0834-8.

The past, present and future of opioid withdrawal assessment: a scoping review of scales and technologies

Joseph K Nuamah  1 , Farzan Sasangohar  1 , Madhav Erraguntla  1 , Ranjana K Mehta  2
Affiliations

The past, present and future of opioid withdrawal assessment: a scoping review of scales and technologies

Joseph K Nuamah et al. BMC Med Inform Decis Mak. .

Erratum in

Abstract

Background: A common challenge with all opioid use disorder treatment paths is withdrawal management. When withdrawal symptoms are not effectively monitored and managed, they lead to relapse which often leads to deadly overdose. A prerequisite for effective opioid withdrawal management is early identification and assessment of withdrawal symptoms.

Objective: The objective of this research was to describe the type and content of opioid withdrawal monitoring methods, including surveys, scales and technology, to identify gaps in research and practice that could inform the design and development of novel withdrawal management technologies.

Methods: A scoping review of literature was conducted. PubMed, EMBASE and Google Scholar were searched using a combination of search terms.

Results: Withdrawal scales are the main method of assessing and quantifying opioid withdrawal intensity. The search yielded 18 different opioid withdrawal scales used within the last 80 years. While traditional opioid withdrawal scales for patient monitoring are commonly used, most scales rely heavily on patients' self-report and frequent observations, and generally suffer from lack of consensus on the criteria used for evaluation, mode of administration, type of reporting (e.g., scales used), frequency of administration, and assessment window.

Conclusions: It is timely to investigate how opioid withdrawal scales can be complemented or replaced with reliable monitoring technologies. Use of noninvasive wearable sensors to continuously monitor physiologic changes associated with opioid withdrawal represents a potential to extend monitoring outside clinical setting.

Keywords: Opioid use disorder; Physiological monitoring; Questionnaires; Scales; Surveys; Wearable sensor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Percent change from baseline year 2000 of opioid deaths (8407 deaths in 2000) vs. heart disease deaths (728,796 deaths in 2000) from 2000 to 2016. For each category, percent change for each year was calculated as [(number of deaths in that year - number of deaths in year 2000)/number of deaths in year 2000] × 100. Data obtained from [6]
Fig. 2
Fig. 2
Process of searching and selecting articles included in the scoping review
Fig. 3
Fig. 3
Timeline of opioid withdrawal scales development
Fig. 4
Fig. 4
a Signs versus number of scales they appeared on; b Symptoms versus number of scales they appeared on
See this image and copyright information in PMC

References

    1. Monwell B, Bülow P, Gerdner A. Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems? Subst Abuse Treat Prev Policy. 2016;11(1):23. - PMC - PubMed
    1. Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357–368. - PubMed
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (fifth edition). Washington, DC: American Psychiatric Association; 2013.
    1. Campbell CI, Bahorik AL, VanVeldhuisen P, Weisner C, Rubinstein AL, Ray GT. Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Prev Med. 2018;110:31–37. - PMC - PubMed
    1. Pravetoni M, Robinson C, Schmiel SE, Mueller DL. Alum adjuvant is more effective than MF59 in promoting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of candidate vaccines against opioid abuse in adult and old mice. J Immunol. 2018;200(1 Supplement):181.20. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources